JPH07116484A - Micro-porous membrane of polyethersulfone and sulfonated polyethersulfone having endotoxin-absorptive power - Google Patents
Micro-porous membrane of polyethersulfone and sulfonated polyethersulfone having endotoxin-absorptive powerInfo
- Publication number
- JPH07116484A JPH07116484A JP28579893A JP28579893A JPH07116484A JP H07116484 A JPH07116484 A JP H07116484A JP 28579893 A JP28579893 A JP 28579893A JP 28579893 A JP28579893 A JP 28579893A JP H07116484 A JPH07116484 A JP H07116484A
- Authority
- JP
- Japan
- Prior art keywords
- polyethersulfone
- endotoxin
- micro
- membrane
- porous membrane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- External Artificial Organs (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、静脈を経て生体内に直
接入る注射液、透析液、輸液などの液体から、有害なエ
ンドトキシンを除去すること、及びこれらの液体の工業
的製造工程において利用することのできる微孔膜に関す
る。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention is used for removing harmful endotoxin from a liquid such as an injection solution, a dialysate solution or an infusion solution which directly enters a living body through a vein, and is used in an industrial production process of these solutions. The present invention relates to a microporous membrane that can be used.
【0002】[0002]
【従来技術】エンドトキシンは、グラム陰性菌細胞壁の
外膜を構成するリポ多糖と蛋白の複合体で、生体内に侵
入すると発熱作用やショック症状を惹起する有害物質で
あり、静脈注射などの際には事前にこれを除去する必要
がある。ところで上記のような液体からエンドトキシン
を除去する方法として、イオンクロマトグラフィ−,ゲ
ルクロマトグラフィ−,アフィニティ−クロマトグラフ
ィ−(特公平1−16389)などが提案されている。
しかし、このイオンクロマトグラフィ−,ゲルクロマト
グラフィ−,アフィニティ−クロマトグラフィ−は、平
衡吸着量が小さい上、PH、イオン強度、再生条件など
条件設定が難しく、実用上有利な方法とは言えない。ま
た逆浸透膜や限外濾過膜を利用した超濾過法は、エンド
トキシンを除去するためにその分子サイズが0.001
μm程度であることから分画分子量6000前後の膜を
用いる必要があり、その流量特性の低さから処理量を多
くするために装置が大型化してくる。さらに濾過に高圧
を要し、ランニングコストが嵩む不利益がある。BACKGROUND OF THE INVENTION Endotoxin is a complex of lipopolysaccharide and protein that constitutes the outer membrane of the cell wall of Gram-negative bacteria. It is a harmful substance that causes fever and shock when it enters the body, and is used for intravenous injection. Needs to remove this in advance. By the way, as a method for removing endotoxin from the above liquid, ion chromatography, gel chromatography, affinity chromatography (Japanese Patent Publication No. 16389) and the like have been proposed.
However, these ion chromatography, gel chromatography, and affinity chromatography are not practically advantageous methods because the equilibrium adsorption amount is small and it is difficult to set conditions such as PH, ionic strength, and regeneration conditions. In addition, the ultrafiltration method using a reverse osmosis membrane or an ultrafiltration membrane has a molecular size of 0.001 in order to remove endotoxin.
Since it is about μm, it is necessary to use a membrane having a molecular weight cut-off of about 6000, and the low flow rate characteristic makes the apparatus large in size in order to increase the throughput. Furthermore, there is a disadvantage that high pressure is required for filtration and running cost increases.
【0003】[0003]
【発明が解決しようとする課題】本発明は、上記実情に
鑑みてなされたもので、エンドトキシンを極低濃度まで
高い処理効率(即ち低圧力)にて除去することが可能で
あり、高流量が得られるポリエ−テルサルホン及びスル
ホン化ポリエ−テルサルホン微孔膜を得ようとするもの
である。SUMMARY OF THE INVENTION The present invention has been made in view of the above circumstances and is capable of removing endotoxin up to an extremely low concentration with high treatment efficiency (that is, low pressure) and high flow rate. It is intended to obtain the obtained polyethersulfone and sulfonated polyethersulfone microporous membrane.
【0004】[0004]
【課題を解決するための手段】上記目的を達成するた
め、本発明者らは、種々研究を重ね、水中に含まれるエ
ンドトキシンがアニオン(陰イオン)に荷電しているこ
とに着目し、流量特性の優れたポリエ−テルサルホン及
びスルホン化ポリエ−テルサルホン微孔膜にカチオン性
を示す樹脂で処理を行い、膜の表面のゼ−タ電位をプラ
スにすることにより、エンドトキシンの吸着能を保持さ
せることに成功したものである。以上の構成の本発明微
孔膜を製造工程的に説明すると、微孔膜の素材である、
ポリエ−テルサルホン樹脂及びスルホン化ポリエ−テル
サルホン樹脂を使用して、常法により、微孔膜を作製す
る(図1)。カチオン性樹脂としては、第四級アンモニ
ウム塩基をもつポリアミド・エピクロロヒドリン樹脂な
どを用いる。このカチオン性樹脂であるポリアミド・エ
ピクロロヒドリン樹脂溶液に前記ポリエ−テルサルホン
及びスルホン化ポリエ−テルサルホン微孔膜を浸漬し、
乾燥後熱処理する。この処理の際、ポリアミド・エピク
ロロヒドリン樹脂溶液にアルカリを加えpH12〜13
にすることにより、処理がさらに効果的に行なわれる。
これにより、膜表面に、正のゼ−タ電位を付与してエン
ドトキシン吸着能を保持させたポリエ−テルサルホン及
びスルホン化ポリエ−テルサルホン微孔膜を得る(図
2)。[Means for Solving the Problems] In order to achieve the above object, the present inventors have conducted various studies, paying attention to the fact that endotoxin contained in water is charged with anion (anion), and The excellent poly (ether sulfone) and sulfonated poly (ether sulfone) microporous membranes are treated with a resin having a cationic property, and the zeta potential on the surface of the membrane is made positive to retain the endotoxin adsorption ability. It was successful. Explaining the manufacturing process of the microporous membrane of the present invention having the above-mentioned structure, it is a raw material of the microporous membrane,
A microporous membrane is prepared by a conventional method using a polyethersulfone resin and a sulfonated polyethersulfone resin (FIG. 1). As the cationic resin, polyamide / epichlorohydrin resin having a quaternary ammonium salt group is used. Immersing the poly (ether sulfone) and sulfonated poly (ether sulfone) microporous membrane in the polyamide / epichlorohydrin resin solution which is this cationic resin,
Heat treatment after drying. At the time of this treatment, alkali is added to the polyamide-epichlorohydrin resin solution to adjust the pH to 12-13.
By doing so, the processing is performed more effectively.
As a result, a polyethersulfone and a sulfonated polyethersulfone microporous membrane in which a positive zeta potential is applied to the membrane surface to retain the endotoxin adsorption ability are obtained (FIG. 2).
【0005】[0005]
【実施例】スルホン化ポリエ−テルサルホン樹脂で孔径
0.2μmの膜を作製し、別に作製したポリアミド・エ
ピクロロヒドリン樹脂水溶液(固形分0.6%,pH1
2〜13)に5分間浸漬後風乾し、さらに100゜Cで
10分間熱処理を行ない、本発明の微孔膜を完成した。EXAMPLE A membrane having a pore size of 0.2 μm was prepared from a sulfonated polyethersulfone resin, and another polyamide / epichlorohydrin resin aqueous solution (solid content 0.6%, pH 1) was prepared separately.
2 to 13) for 5 minutes, air-dried, and further heat-treated at 100 ° C. for 10 minutes to complete the microporous membrane of the present invention.
【0006】[0006]
【エンドトキシン除去試験結果(1)】上記により得ら
れた微孔膜を、予め250゜Cで1時間乾熱滅菌したホ
ルダ−にφ47mmの試料としてセットし、次に20m
lのエンドトキシンフリ−水で洗浄した。その後、流量
50ml/min/φ47mmエンドトキシン水溶液
(濃度201EU/ml)の濾過を行ない、濾過液のエ
ンドトキシン濃度をゲル化転倒法(ゲル化感度0.03
EU/ml)により測定した。その結果、400mlま
で濾液のエンドトキシン濃度が0.03EU/ml以下
となり、高いエンドトキシン吸着量を示した。エンドト
キシン吸着除去状態を図3によって示す。なお、これと
対比して同一条件においてポリアミド・エピクロロヒド
リン樹脂水溶液で処理しない場合の除去試験を行なって
みたところ、エンドトキシンの吸着は全く見られなかっ
た。[Results of endotoxin removal test (1)] The microporous membrane obtained above was set as a φ47 mm sample in a holder that had been dry heat sterilized at 250 ° C. for 1 hour in advance, and then 20 m.
Washed with 1 of endotoxin free water. After that, a 50 ml / min / φ47 mm endotoxin aqueous solution (concentration: 201 EU / ml) was filtered, and the endotoxin concentration of the filtrate was determined by gel inversion (gelation sensitivity 0.03).
EU / ml). As a result, the endotoxin concentration in the filtrate was 0.03 EU / ml or less up to 400 ml, indicating a high endotoxin adsorption amount. The endotoxin adsorption removal state is shown by FIG. In contrast to this, when a removal test was carried out under the same conditions without treatment with the polyamide-epichlorohydrin resin aqueous solution, endotoxin adsorption was not observed at all.
【0007】[0007]
【エンドトキシン除去試験結果(2)】実施例にて得た
微孔膜を襞状に折り膜面積4000cm2 のカ−トリッ
ジフィルタ−を作製し、これを、予め250C゜で一時
間乾熱滅菌したカ−トリッジハウジングにセットした。
その後、流量5l/min/4000cm2 でエンドト
キシン水溶液(濃度20EU/ml)の濾過を行ない、
濾過液のエンドトキシン濃度をゲル化転倒法(ゲル化感
度0.03EU/ml)により測定した。その結果、1
200lまで濾液のエンドトキシン濃度が0.03EU
/ml以下となり、高いエンドトキシン吸着量を示し
た。エンドトキシン吸着除去状態を図3によって示す。
なお、これと対比して同一条件においてポリアミド・エ
ピクロロヒドリン樹脂水溶液で処理しない微孔膜を用い
て先と同様のカ−トリッジフィルタ−を作製し、除去試
験を行なったところ、エンドトキシンの吸着は全く見ら
れなかった。[Endotoxin removal test results (2)] A microporous membrane obtained in the example was folded to form a cartridge filter having a folded membrane area of 4000 cm 2 , which was previously sterilized by dry heat at 250 ° C for 1 hour. It was set in the cartridge housing.
Then, the endotoxin aqueous solution (concentration 20 EU / ml) was filtered at a flow rate of 5 l / min / 4000 cm 2 ,
The endotoxin concentration of the filtrate was measured by the gel inversion method (gelation sensitivity 0.03 EU / ml). As a result, 1
The endotoxin concentration of the filtrate is 0.03 EU up to 200 l.
/ Ml or less, showing a high endotoxin adsorption amount. The endotoxin adsorption removal state is shown by FIG.
In contrast to this, a cartridge filter similar to the above was prepared using a microporous membrane which was not treated with an aqueous solution of a polyamide-epichlorohydrin resin under the same conditions, and a removal test was carried out. Was not seen at all.
【0008】[0008]
【発明の効果】本発明は以上のようで、所期の目的、即
ちエンドトキシン含有液からエンドトキシンを極低濃度
まで高い処理効率にて除去することが可能であり、高流
量が得られるポリエ−テルサルホン及びスルホン化ポリ
エ−テルサルホン微孔膜を提供するものであり、医療、
製薬等の分野でその利用が大いに期待される。The present invention is as described above, and the intended purpose, that is, it is possible to remove endotoxin from an endotoxin-containing liquid to a very low concentration with high treatment efficiency, and a high flow rate of polyethersulfone can be obtained. And a sulfonated polyethersulfone microporous membrane for medical treatment,
There are great expectations for its use in fields such as pharmaceuticals.
【図1】カチオン樹脂処理前のポリエ−テルサルホン及
びスルホン化ポリエ−テルサルホン微孔膜の略図的拡大
縦断面図FIG. 1 is a schematic enlarged longitudinal sectional view of a poly (ether sulfone) and a sulfonated poly (ether sulfone) microporous membrane before treatment with a cationic resin.
【図2】カチオン樹脂処理後の同上略図的拡大縦断面図FIG. 2 is a schematic enlarged vertical sectional view of the same as above, after treatment with a cation resin.
【図3】エンドトキシン吸着除去状態を示す略図的拡大
縦断面図FIG. 3 is a schematic enlarged vertical cross-sectional view showing a state of adsorbing and removing endotoxin.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 C08L 71/10 LQK 81/02 LRG ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Office reference number FI technical display location C08L 71/10 LQK 81/02 LRG
Claims (1)
してエンドトキシン吸着能を保持させたポリエ−テルサ
ルホン及びスルホン化ポリエ−テルサルホン微孔膜。1. Polyethersulfone and sulfonated polyethersulfone microporous membranes, wherein a cationic resin is applied with a positive zeta potential to retain endotoxin adsorption ability.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP28579893A JP3415222B2 (en) | 1993-10-20 | 1993-10-20 | Polyethersulfone or sulfonated polyethersulfone microporous membrane with endotoxin adsorption ability |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP28579893A JP3415222B2 (en) | 1993-10-20 | 1993-10-20 | Polyethersulfone or sulfonated polyethersulfone microporous membrane with endotoxin adsorption ability |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH07116484A true JPH07116484A (en) | 1995-05-09 |
JP3415222B2 JP3415222B2 (en) | 2003-06-09 |
Family
ID=17696221
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP28579893A Expired - Lifetime JP3415222B2 (en) | 1993-10-20 | 1993-10-20 | Polyethersulfone or sulfonated polyethersulfone microporous membrane with endotoxin adsorption ability |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3415222B2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0740951A1 (en) * | 1995-04-20 | 1996-11-06 | GAMBRO DIALYSATOREN GMBH & CO. KG | Sterilisable membrane by heat treatment |
JP2002538945A (en) * | 1999-03-03 | 2002-11-19 | プリスメディカル コーポレーション | Improved water purification pack |
EP1424124A1 (en) * | 2002-11-30 | 2004-06-02 | Gambro Lundia AB | Membrane and use thereof |
EP2462158B1 (en) | 2009-08-06 | 2018-01-10 | F. Hoffmann-La Roche AG | Method to improve virus removal in protein purification |
-
1993
- 1993-10-20 JP JP28579893A patent/JP3415222B2/en not_active Expired - Lifetime
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0740951A1 (en) * | 1995-04-20 | 1996-11-06 | GAMBRO DIALYSATOREN GMBH & CO. KG | Sterilisable membrane by heat treatment |
JP2002538945A (en) * | 1999-03-03 | 2002-11-19 | プリスメディカル コーポレーション | Improved water purification pack |
EP1424124A1 (en) * | 2002-11-30 | 2004-06-02 | Gambro Lundia AB | Membrane and use thereof |
WO2004050222A1 (en) * | 2002-11-30 | 2004-06-17 | Gambro Lundia Ab | Membrane and use thereof |
EP2462158B1 (en) | 2009-08-06 | 2018-01-10 | F. Hoffmann-La Roche AG | Method to improve virus removal in protein purification |
US10662237B2 (en) | 2009-08-06 | 2020-05-26 | Genentech, Inc. | Method to improve virus filtration capacity |
US11225513B2 (en) | 2009-08-06 | 2022-01-18 | Genentech, Inc. | Method to improve virus filtration capacity |
Also Published As
Publication number | Publication date |
---|---|
JP3415222B2 (en) | 2003-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4376707A (en) | Process for the removal of urea from blood wash fluids and blood | |
JP2004525747A (en) | Cartridge useful for washing dialysate | |
US5136032A (en) | Method for separating phosphopolyol compounds using a separating agent | |
JPH01194991A (en) | Pyrogen removal method | |
EP4003575A2 (en) | Method and system for preparing dialysis fluid from raw water | |
JP3617194B2 (en) | Permselective separation membrane and method for producing the same | |
JPH07116484A (en) | Micro-porous membrane of polyethersulfone and sulfonated polyethersulfone having endotoxin-absorptive power | |
JPH10230148A (en) | Semipermeable membrane | |
JP3239239B2 (en) | Cellulose-based microporous membrane with endotoxin adsorption ability | |
JPH04176330A (en) | Production of charge type separation membrane | |
SU628804A3 (en) | Method of purification of organic solutions from accompoanying admixtures | |
JP4483230B2 (en) | Membrane for plasma separation and blood purification system using the same | |
JPH0260660A (en) | Adsorbent for treating body fluid | |
CN109174022B (en) | Method for immobilizing adsorption material for blood purification | |
JPH0970431A (en) | Production of polysulfone hollow fiber type artificial kidney and artificial kidney | |
GB2067200A (en) | Separation of plasma albumin by ultra filtration | |
JPH0689093B2 (en) | Separation functional jelly | |
JP2003010655A (en) | Porous membrane and method for producing the same | |
SU844569A1 (en) | Method of preparing homocompatible adsorbents for blood purification from toxins | |
JPH06279296A (en) | Removal of associated protein from plasma fraction preparation | |
Vienken et al. | Dialysis Membranes—The Heart of the Dialyzer | |
JPWO2002083202A1 (en) | Body fluid treatment adsorber | |
JPH02180626A (en) | Microporous membrane of polyamide | |
JPH04348757A (en) | Method and device for treating dialyzate | |
JP3489372B2 (en) | Perm-selective separation membrane |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120404 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120404 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140404 Year of fee payment: 11 |
|
EXPY | Cancellation because of completion of term |